Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: ClearPoint Neuro Inc., 3 years.
ClearPoint Neuro Inc.
Director
PTC Therapeutics Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
PTC Therapeutics Inc.
· CHIEF EXECUTIVE OFFICER
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 4, 2026 | PTC Therapeutics Inc. | Open-market sale | −10,292 | $68.57 | $705,722 |
| May 21, 2026 | ClearPoint Neuro Inc. | Open-market sale | −16,000 | $11.59 | $185,440 |
| May 19, 2026 | ClearPoint Neuro Inc. | Option exercise | +12,417 | — | — |
| May 14, 2026 | PTC Therapeutics Inc. | Open-market sale | −679 | $73.06 | $49,608 |
| May 14, 2026 | PTC Therapeutics Inc. | Open-market sale | −7,221 | $73.08 | $527,711 |
| May 14, 2026 | PTC Therapeutics Inc. | Open-market sale | −2,100 | $73.08 | $153,468 |
| May 14, 2026 | PTC Therapeutics Inc. | Open-market sale | −2,572 | $72.46 | $186,367 |
| May 13, 2026 | PTC Therapeutics Inc. | Grant or award | +12,500 | — | — |
| Apr 21, 2026 | PTC Therapeutics Inc. | Open-market sale | −2,850 | $70.91 | $202,094 |
| Mar 12, 2026 | PTC Therapeutics Inc. | Open-market sale | −2,662 | $64.08 | $170,581 |
| Mar 11, 2026 | PTC Therapeutics Inc. | Grant or award | +12,500 | — | — |
| Feb 18, 2026 | PTC Therapeutics Inc. | Open-market sale | −7,371 | $69.36 | $511,253 |
| Jan 8, 2026 | PTC Therapeutics Inc. | Open-market sale | −2,514 | $76.45 | $192,195 |
| Jan 7, 2026 | PTC Therapeutics Inc. | Open-market sale | −3,016 | $77.48 | $233,680 |
| Jan 6, 2026 | PTC Therapeutics Inc. | Open-market sale | −5,149 | $76.95 | $396,216 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.